HS 4203-29-90-92 – Women's or girls'

Tariff data as of T2026-2, effective Sept 1, 2026, last verified Oct 21, 2026

Articles of apparel and clothing accessories, of leather or of composition leather. › Other › Women's or girls'

MFN duty rate

15.5 %

GST

5%

Unit of measure

PAR

Women's or girls'

Estimate duty & taxes · Get classification help

Preferential tariff rates

• LDCT: Free
• Switzerland–Liechtenstein (SLT): Free
• CPTPP – United Kingdom (CPUKT): Free
• Peru: Free
• Colombia: Free
• Jordan (JT): Free
• Iceland: Free
• UK: Free
• Australia: 8.5%
• New Zealand: 8.5%
• MXT/CUSMA (Mexico): Free
• UST/CUSMA (US): Free
• GPT: 10%
• Panama (PAT): Free
• Norway (NT): Free
• Korea: Free
• CPTPP: Free
• Costa Rica (CRT): Free
• Israel (CIAT): Free
• Commonwealth Caribbean Countries Tariff (CCCT): Free
• CETA: Free
• Ukraine: Free
• Honduras (HNT): Free
• Chile: Free

Preference requires qualifying origin and origin proof or certification.

Frequently asked questions

What is the MFN duty on Women's or girls' (HS 4203-29-90-92)?

The T2026-2 MFN rate for tariff item 4203.29.90 is 15.5%. Specific or compound rates require manual calculation. Classification and origin must be verified with CBSA.

What is the duty on HS 4203-29-90-92 from the US?

Qualifying US-origin goods with origin proof use UST/CUSMA at Free. This item is not on any US surtax schedule in force in TariffPlus surtax data (checked against CBSA). GST/HST and any applicable personal-import provincial tax are additional.

Which trade agreement rates apply to HS 4203-29-90-92?

LDCT: Free; Switzerland–Liechtenstein (SLT): Free; CPTPP – United Kingdom (CPUKT): Free; Peru: Free; Colombia: Free; Jordan (JT): Free; Iceland: Free; UK: Free; Australia: 8.5%; New Zealand: 8.5%; MXT/CUSMA (Mexico): Free; UST/CUSMA (US): Free; GPT: 10%; Panama (PAT): Free; Norway (NT): Free; Korea: Free; CPTPP: Free; Costa Rica (CRT): Free; Israel (CIAT): Free; Commonwealth Caribbean Countries Tariff (CCCT): Free; CETA: Free; Ukraine: Free; Honduras (HNT): Free; Chile: Free. Preferential treatment requires qualifying origin and certification. Rates are informational; CBSA is authoritative.